Penn Vet | Therapies & Trials
Novel Therapies and Clinical Trials

Novel Therapies & Clinical Trials

Current Trials

Use of the PI3K inhibitor copanlisib to treat splenic hemangiosarcoma

In this trial, we will be evaluating the safety and effect of copanlisib on survival of dogs with splenic hemangiosarcoma

inactive Mason Active hemangiosarcoma clinical trial cancer Brian Flesner

Pilot Study of xenograft chimeric antigen receptor T cell therapy for drug resistant or refractory CD20+ B cell Lymphoma

T cell therapy for drug resistant B cell Lymphoma

Mason Active lymphoma dogs canine cancer active cancer B-cell lymphoma active

Evaluation of Nemo Binding Domain (NBD) peptide for dogs with soft tissue sarcoma

NBD Peptide for Soft Tissue Sarcoma

Mason Active tumor soft tissue sarcoma sarcoma mass cancer center Cancer Care cancer active